Cleared Traditional

K192886 - OmniWire Pressure Guide Wire

K192886 is the FDA 510(k) clearance for OmniWire Pressure Guide Wire by Volcano Corporation. It is a Class 2 Cardiovascular device (product code DQX) cleared through the Traditional 510(k) pathway after a 168-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
168d
Days
Class 2
Risk

K192886 is an FDA 510(k) clearance for the OmniWire Pressure Guide Wire, 185 cm Straight Tip, OmniWire Pressure Guide Wi.... Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Volcano Corporation (San Diego, US). The FDA issued a Cleared decision on March 26, 2020 after a review of 168 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Volcano Corporation devices

Submission Details

510(k) Number K192886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 10, 2019
Decision Date March 26, 2020
Days to Decision 168 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d slower than avg
Panel avg: 125d · This submission: 168d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 500
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K192886.
LiteSaber Wire Torque Assist Device
K200120 · Vesatek, LLC · May 2020
Go2Wire Guide Wire
K193571 · Merit Medical System, Inc. · Apr 2020
HI-TORQUE Steelcore Bare Guide Wire
K200144 · Abbott Vascular · Apr 2020
Mirage Hydrophilic Guidewire, X-pedion Hydrophilic Guidewire
K193548 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Jan 2020
Wattson Temporary Pacing Guidewire
K192454 · Vascular Solutions · Jan 2020
OptoWire III
K191907 · Opsens, Inc. · Jan 2020